VIVUS, Inc
-
Ticker
VVUS
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Mountain View, California
VIVUS, Inc., a biopharmaceutical company, is developing therapies to address obesity, sleep apnea, diabetes, and male sexual health. Its lead investigational product, Qnexa, has completed Phase 3 clinical trials for the treatment of obesity. Qnexa is also in Phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea.
REPORT RATINGS
4.8 / 5.0 (244)
VIVUS, Inc reports have an aggregate usefulness score of 4.8 based on 244 reviews.
VIVUS, Inc
Most Recent Annual Report
MOST RECENT
2019 Annual Report and Form 10K
Older/Archived Annual Reports